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CHAPTER I 
HISTORICAL 
Introduction 
The word "retinoid" is a general term that is commonly applied to both the naturally 
occurring compounds 1-10 with vitamin A activity and synthetic analogues 10-15, with 
or without the biological activity of vitaman A (1). 59 Thus a material has been classified 
2 
3 
4 
OH 
1, retinol 
3, all-trans-retinoic acid 
C02H 
5, 13-cis-retinoic acid 
1 
2, all-trans-retinal 
HO 
4, 13-cis-retinol 
CHO 
z 
6, Z = COzH (11-cis-retinoic acid) 
7, Z = CHO (11-cis-retinal) 
z 
8, Z = CH2NHCH2CH20H 
9, Z = C(O)NHC2H5 
2 
under the nomenclature of retinoids if the compound possessed a structural relationship 
reminiscent of the parent retinol, 64 even if the compound was devoid of activity associated 
with vitamin A. Retinoids have also been designated structurally as compounds consisting 
of four isoprenoid units joined in a head-to-tail manner.34 Arotinoids 10-12 are retinoids 
with a least one aryl ring in the system.46,47 Heteroarotinoids 13 and 14 possess an 
aryl ring and at least one heteroatom in the ring system (or possibly in the side chain in 
some cases).l3,66,72 
10, Etretinate 
13, X = 0, S02, NR, S 
AROTINOIDS 
C02Et 
HETEROAROTINOIDS 
z 
Z == C02H, C02Et, C02Me 
14a, X= 0 
R=Et 
14b, X= S 
R=Et 
3 
Background 
Since ancient times, it was believed that a substance existed in the diet which was 
necessary for night vision. However, only at the beginning of this century was it shown 
that a fat soluble compound (later named vitamin A) not only prevented night blindness32 
but also promoted growth in rats.32 In 1937, Holmes and Corbet were able to crystallize 
pure retinol (1).32 An important discovery in this field wa~ the identification by Wald 
(1934)69 and by Morton (1944)49 of the chromophore of the visual pigment, namely retinal 
(2). However, it is unclear as io what form or derivatives of retinol is involved in the 
other biological functions such as growth promotion, , reproduction, differentiation, and 
maintenance of epithelial tissues as illustrated. 
RETINAL 
VISION 
DIET 
DIGESTIVE SYSfEM 
[INTESTINE (RETINYL ESI'ERS); UVER] 
1 
,..._ RETINOL RETINOIC ACID 
REPRODUCTION 1. GROWfH PROMOTION 
2. DIFFERENTION AND MAINTENANCE 
OF EPITHEUAL TISSUE 
It appears that no single retinoid is able to function alone in all the varied aspects of 
vitamin A activity which suggests that different metabolites of retinoids may be responsible 
for vitamin A and related types of activity. Thus it is important to understand the 
4 
metabolism of natural retinoids and the nature of various metabolites. Recent treatises 
focus on the potential carcinostatic property of retinoids, metabolites therefrom, and certain 
structure-activity relatio~ships uncovered.4,13,54,63 
Metabolism of Natural Retinoids 
Until the introduction of synthetic'retinoids into food, .B-carotene (15), a natural plant 
product, was the major dietary source of retinol (1). This compound is cleaved into two 
molecules of retinal (2)28,63 by a soluble enzyme (.B-carotene 15,15'-oxygenase) found in 
the intestine and in the liver.28,63 The reaction requires molecular oxygen and is inhibited 
by sulfbydryl group inhibitors and by chelators of ferrous ion_l5,16 The enzyme involved 
in this conversion (retinaldehyde reductase) is found not only in the intestine but also in the 
liver73 and in the eye.6 Alcohol dehydrogenase can also convert retinol (1) to retinal (2).6 
It has been postulated that in rat liver both the retinaldehyde reductase and the alcohol 
dehydrogenase activity reside in the same enzyme.73 
LIVER, 
INTESTINE 
15, .B-Carotene 
EYE, 
z RETINAL LNER, INTESTINE .... 2RETINOL 
It is believed that after binding to a specific protein to form a complex, retinol (1) is 
transported to cells.41 The major metabolic pathway for 1 can involve either oxidation or a 
non oxidative pathway. 65 Many oxidative paths have been suggested by different research 
groups)7,20-22,31,48,57,74 It is clear from structures 16-22 that oxidation can occur at 
5 
several sites. After analysis of these structures, one might conclude that the metabolic 
degradation sites are: (1) oxidation at C(4), (2) epoxidation of the double bond in the 
cyclohexyl ring, (3) oxidation of one of the methyl carbons of the geminal dimethyl pairs, 
2 
3 
OH 
0 
3, trans-retinoic acid 
0 
19 
21 
0 
HO 
0 
22 
(4) oxidation of the methyl group at C(5), and (5) shortening of the polyene side chain with 
partial oxidation-reduction of the conjugated system. In general, oxidation may occur at a 
double bond in 3, such as to give 17 and 18, at a carbon atom one bond removed from a 
double bond,such as to give 16 and 19-22, or at carbon atom two bonds removed from a 
6 
double bond such as to give 19 and 20. Nonoxidative pathways have also been 
suggested),l5,29 These involve either isomerization17 of the double bond in the ring or 
formation of an ester involving retinol and a carboxylic acid [like stearic or palmitic29 as in 
23 and 24] or phosphoric acid (like 25). 
Fatty acyl-coA: 
Retinol acyltranferase 
23, Retinyl palrmtate 
R = C1sH31 
+ 
24, Retinyl stearare 
R = CH2(CH2)t6CH3 
<J 
I -
0-PO 
GDP- Mannose J t 
GDP )~ Retinyl phopsphate 
II 
0 
Current research seeks to determine if any metabolite of vitamin A, or that of its 
synthetic analogues, may have activity equivalent or superior to that of all-trans-(3) or 13-
cis-retinoic acid (5). Since specific biological activities may in reality reside with 
metabolities of retinoids, it is very important to understand the metabolic pathways. Such 
information can aid in strategy to design synthetic analogues to have specific properties. A 
growing awareness in this area of research includes the structural correlations, especially 
7 
the geometric and spatial arrangements of atoms which play a pivotal role in distinguishing 
metabolites and their specific biological activities. The concept of "a better fit" of the 
synthetic analogues on a structural basis could result in better binding characteristics of 
retinoids, 13,25,36 such as involved with the protein complex cellular retinol binding protein 
(cRBP). This theory is gaining acceptance)4,25 
Mechanism of Action 
Numerous theories for the mechanism of action of retinoids have been reported in 
several detailed reviews. 3,54,63 Although the exact mechanism of action of retinoids is not 
completely understood (especially at the gene level), it is now thought from the many in 
vitro and the in vivo studies that retinoids affect the gene expression.43,58 This process 
may have a direct relation tp the observed biological effects. It is believed that albumin 54 
picks up the retinoic acid and the retinol in blood and delivers such to cells. At the cell 
surface, these retinoids are bound to a protein receptor,11,58,61 namely, the cellular retinol 
binding protein (cRBP) and the cellular retinoic acid binding protein (cRABP). The 
receptors involved have been isolated and characterized.50-53 The complex (between the 
retinoid and protein receptor) apparently penetrates the nuclear membrane and enters into 
the nucleoplasm to deliver the retinol to the chromatin (a type of complex present in the 
chromosome). Green and co-workers 24 showed that a type of katrtin (67-kDa, fibrous 
protein) was suppressed by the retinoids at the mRNA level. Later it was discovered71 that 
retinoids act at the DNA level in F9 cells (a type of cancer cell). Evans and co-workers 26 
and Chambon and co-workers '55 were able to characterize and illustrate the importance of 
certain human protein receptors which contain a DNA binding site as well as a retinoid 
binding site. All the above findings suggest that many of the biological activities of the 
retinoids can be attributed, at least in part, to an ability to act at the gene level (regulation of 
the gene expression) by forming complexes with specific binding protein receptors, 
8 
although the exact nature of the binding in the nucleus [that is, whether the binding includes 
DNA, RNA, or chromatin] is not certain. 
Synthetic Retinoids: (Arotinoids) 
Retinoids with an aryl ring incorporated in the basic retinoic acid skeleton have been 
classified under the name of "arotinoids". Early work in this area began via the discovery 
of the Hoffmann-La Roche Company that the incorporation of an aromatic ring into the 
basic system caused a dramatic increase in the therapeutic ratio [the therapeutic ratio was 
determined from the dose (mglkg) which caused 50% regression of papillomas in Swiss 
mice relative to that dose (mglkg) which produced hypervitaminoses A syndrome] of such 
retinoids.46,47 This resulted in the development of "Etretinate" (10), now a commercial 
agent.7,31,46 The success in the commercialization of therapeutically useful retinoids led to 
investigations and the synthesis of similar compounds.7,31,47 Compounds 26-31 are 
metabolites of 10. 
26, Etretin . 
9 
Five- and six-membered rings have also been incorporated into the basic system and 
biological activities have been determined 7,47 for several compounds. Arotinoids 32-37 
are a few examples of novel, synthetic arotinoids reported. 
34 
37 
Many arotinoids exibited high antipapilloma activity (ability to cause regression of a 
certain type of skin tumor).46 This led to the synthesis of (E)-4-[2-(5,6,7,8-tetrahydro-
5,5,8,8-tetramethyl-2-naphthalyl)-1-propenyl]benzoic acid (TTNPB, 32), an arotinoid 
with a fused six-membered ring and with another aromatic ring incorporated into the side 
chain)3,46 Biological activities, toxicity assays, and various metabolites of Etretinate 
(10), TTNPB (32), and other arotinoids have been examined and some of the results are 
tabulated in Tables I and II. More tests have been reported for retinoids with carboxyl 
groups since it is believed that the carboxyl group is important for the retinoid to bind in 
vivo to cRABP.35 
TABLE I 
ACTIVITY OF SELECTED RETINOIDS IN TOC AND ODC ASSAYSa 
Arotinoid 
~CO,H 
C02H 
~COzH ~ 
A: 
34 
~CO,H 
~ 
I 
35 
C02H 
aprom Reference 13. 
TOCAssayb 
EDso. nmol 
mglkg/day 
1 x w-11 
1 x w-12 
6 x w-10 
3 x w-10 
3 x w-10 
bTracheal organ culture assay, Reference 67 and 68. 
cornithine decarboxylase assay, Reference 67 and 68. 
Dose, 
nrnol %Inhibitiond 
1.7 88 
17 91 
1.7 81 
17 69 
1.7 33 
17 77 
1.7 34 
17 80 
1.7 58 
d% inhibition= [100 x ODC activity (retinoid)-ODC activity (control)]/ODC 
activity (control) 
10 
11 
TABLE II 
THE ABILITY OF AROTINOIDS TO INDUCE DIFFERENTIATION IN TIIE ffiJMAN 
PROMYELOCYTIC LEUKEMIA CELL LINE (HL-60) AND TO INIDBIT 
CO:MPLETEL Y SCALE FORMATION IN THE SKIN OF THE 
Arotinoid 
FOOT OF CHICK EMBRYOa 
Induction of Differentiation 
HL-60 Assayb, ED so 
1 x w-8 
d 
Complete 
Inhibition 
10-5 
10-8 
10-8 
-------------------------------------------------------------aReference 7. 
bReference 8 and 9. 
CNot an arotinoid but included for comparision. 
dfiL-60 activity not reported. 
eReference 71. 
12 
Heteroarotinoids 
The undesirable toxicity level of arotinoids has prompted further research in terms of 
structure modification. Heteroarotinoids are a group of heterocycles which retain some 
features of the retinoid skeleton but have special characteristics in that at least one aryl ring 
and one heteroatom are incorporated into the basic system.l3,66,72 Structures of some 
heteraoarotinoids 38-52 synthesized recently are given below. Several of these 
heteroarotinoids exhibited marked activity in the ODC (Table III) and TOC assays (see 
section entitled Activity of Retinoids)13,45,72 and some (like compounds 38 and 39) have 
demonstrated much less toxicity (table IV) than the hydrocarbon standard 32.13,45,59 
C02Me 
40 
42 
CO~e 
41 
43 
C02Me 
51, X= 0 
52, X= S 
13 
As discussed previously, the oxidation of trans-retinoic acid (3) occurs at C(4)57 to give 
16 and at the C(5)=C(6) bond48 to give 18. Thus, the introduction of a heteroatom at 
C(4) and protecting theC(5)=C(6) bond by incorporation of an aromatic ring could result in 
a molecule with increased hydrophilicity, improved transport properties, and hopefully 
14 
18 
0 
with reduced overall toxicity. Based on these hypotheses, work of Berlin 
and co-workers and that of Dawson and co-workers produced heteroarotinoids 13 with X 
= 0, S and S(O) at C( 4) and with a fused aryl ring as illustrated. 
z 
13, x = o, so2, NH, s 
Z = C02H, C02Et, C02Me 
Activity of Retinoids 
One major problem with many retinoids is the acute toxicity.39 Large doses of 
retinoids can lead to a symptom called the "Hypervitaminoses A syndrom" which is 
associated with several toxic side effects such as headaches, nausea, vomiting, dryness, 
and scaling.44 Several commercially available retinoids also exhibit undesirable toxicity. 
For example, Etretinate (10) has been reported to cause abnormal liver functions and acute 
teratogenic properties due, in part, to an enhanced biological half life. 44 Tretinoin [one of 
the commercial names for all-trans-retinoic acid (3)] is said to cause hypopigmentation44 
and skin problems (like irritation, redness and scaling) along with other common side 
effects cited earlier. The toxicity studies are generally conducted on live rats and the LDso 
values are compared.13,6 
Among the many assays used to assess activity and toxicity of test retinoids, two are 
prominent and commonly used. They are the ornithine decarboxylase (ODC) assay, which 
15 
is an in vivo 67,68 method, and the human promyelocytic leukemia cell line (HL-60) assay, 
which is an in vitro.8,9 method. The compound 12-0-tetradecanoylphorbol-13-acetate 
(TP A) is labelled a cancer promoter and an inducer of the production of the enzyme 
ornithine decarboxylase, which in turn reacts with ornithine. 67 It is believed that ornithine 
decarboxylase assists in the transformation of normal to malignant cells.67,68 Since many 
retinoids have the ablity to inhibit ornithine decarboxylase induction, the ODC assay has 
become a reliable method to study antitumor properties of synthetic retinoids.67,68 The 
ODC activity is determined by measuring the C02 evolved when a suspension of malignant 
tissue and 14C-labelled ornithine are mixed.67,68 
The other method (HL-60 assay) involves cell differentiation.8-10 Normal HL-60 cells 
do not produce superoxide ions when stimulated by TPA, whereas differentiated HL-60 
cells do produce such superoxide ions ( 02- ions produced by an oxidative metabolic 
pathway as a part of body's defense mechanism),lO which can be detected by a change in 
color of the test dye, nitroblue tetrazolium (from yellow to blue).9,10 The ODC activity of 
certain heteroarotinoids (38, 39 and 44) in comparison with trans-retinoic acid 3 is shown 
in Table III and the toxicity studies ( of heteroarotinoids 38 and 39) are tabulated in Table 
IV As illustrated in Table IV the toxicity was determined by measuring the mortality of 
female Swiss mice.45 None of the mice survived with arotinoid 32 at a dose of 30 
Jlmollkg/day for 8 days whereas all the animals survived with a similar dose of trans-
retinoic acid (3, 33 Jlmol/kg/day). With heteroarotinoid 38, toxicity levels were 
determined and compared [with those of retinoic acid (3)] at a dose of 600 JlmoL/kg/day 
for 7-10 days with the survival rate being 70% [compared to 95% with retinoic acid (3)]. 
With the sulfur analogue 39, no deaths were reported until day 8. Toxicity studies have 
been performed recently45 to demonstrate the decreased toxicity of certain heteroarotinoids. 
New varieties of heteroarotinoids have been synthesized13,14,19,22,37,38,56,71 in an attempt 
to minimize the toxicity levels. 
TABLE III 
ACTIVITY OF SELECTED HETEROAROTINOIDSa 
(ORNITHINE DECARBOXYLASE ASSA Y)b 
Test system 
Acetone + TP A 
Acetone+ TPA + t-RA (3) 
~CO,H ~ 
.& 
0 38 
~~H ~ 
~ 
s 3!1 
~co~ ~ 
I 0 44 
aReferences 13, 25, 61. 
hRererences 67, 68. 
Dose (nmol) nmol of C02130- % 
min/mg of Protein inhibitionc 
10 1.02 Control 
34 0.13 87 
34 0.090 91 
34 0.283 72 
17 d 85 
C% inhibition= [100 x ODC activity (retinoid)-ODC activity (control)]/ODC 
activity (control) 
dData not available. 
16 
17 
TABLEN 
TOXICITY OF SELECTED RETINOIDS IN FEMALE SWISS MICEa,b 
Dose % Survivers Days of Total 
Retinoids JJ.mollkg day Days 8 Days 15 Death Animals 
Control 0 100 100 30 
Retinoic acid (3) 600 95 0 7-13 20 
300 100 0 10-14 20 
200 100 63 14-15 30 
100 100 100 30 
67 100 100 20 
33 100 100 10 
TTNPB 32 30 50 0 6-8 20 
10 87 0 7-10 30 
3.3 97 0 7-11 30 
1.0 100 30 10-15 30 
Arotinoid 37 100 100 0 8 10 
30 100 0 9-12 10 
10 100 68 10-15 30 
3.3 100 100 10 
Heteroarotinoid 38 600 70 0 7-10 10 
300 100 50, 12-15 10 
200 100 90 14 10 
100 100 100 10 
30 100 100 10 
Heteroarotinoid 39 600 100 0 9-10 10 
300 100 80 14-15 10 
100 100 100 10 
30 100 100 10 
aReference 13. 
bRetinoids administered by ip injection on week days over period of 2 weeks. 
18 
Structure-Activity Correlation of Retinoids. 
The evolution of heteroarotinoids has involved several logical considerations and are, 
in part, based on the assumption that the heteroatom might reduce toxicity. For example, a 
heteroatom was introduced to avoid oxidation at C(4), and an aryl group was incorporated 
to block oxidation at the C(5)=C(6) position)3,56,72 These are slight modifications which 
do not appear to alter appreciably the overall spatial requirement of the system. 
Understanding the structural and stereochemical properties of a compound and its 
correlation with biological activity is considered vital in any medicinal and biologically 
oriented research)3, 14,72 
The structural similarity of a heteroarotinoid 13 to that of the all-trans-retinoic acid (3), 
as illustrated below, suggests that the heteroaroti.noid could mimic the action of the natural 
retinoid at the celluar level, or in short, it should have an appropriate "fit". Certain X-ray 
studies have been performed on a single crystal of 45 25 and the data have been analyzed 
2 
3 
3 
11 
~ 
All-trans-retinoic acid Heteroaroti.noid 
via molecular graphics to determine the "fit" with natural retinoic acid (3). Several 
3, aU-~nVU-retinoic acid 
z 
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modified retinoids based on certain structure-activity correlations have been 
reported13,14,25,36,37,56,60 with most of the work being focused upon reducing the toxicity 
and increasing the ability of the retinoid to bind with a protein.14,25 Shudo and co-
workers36,37 replaced the propenyl group of retinoid 32 with hetero functional groups 
such a C(O)NH and N=N [compounds of the type 53 and 54 (55 and 56)]. From the 
32 
53 
activity found for the amides, 55 and 56 (Table V) it was concluded that a 
hydrophilic group joined by a bridge X to a benzoic acid group,with sufficient steric bulk, 
was required for biological. activity. The testing results did not, however, emphasize any 
spatial requirements for the the bridge. 36,37 Certain conformationally restricted retinoids 
(57 and 58) with methyl groups on the double bond [C(9)=C(l0)] and with rings 
(cylopropyl and naphthyl, as in 37 and 59) at the double bond [C(9)=C(10)], retinoic acid 
TABIEV 
DIFFERENTIATION-INDUCING ACTIVITIES OF RETINOIDAL 
AMIDE COMPOUNDS ON HL-60 CELLSa 
Retinoid EDso,M Rel. act.b 
~ ~ ~ C02H 2.4 x w-9 100 
3 
~~~COzH 
7.9 X 10-lO 350 
0 
55 
0 OC02H WN ,._I 3.4 x w-lo 720 
I 
H 
56 -
aReference 36. 
hRelative activity is defined as the mean value of the ratio EDso (retinoic acid) to 
EDso (test compounds), both values having been obtained in concurrent 
experiments. 
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numbering] were synthesised recently by Dawson and co-workers14 and involved 
C02H C02H 
2 
3 
37 57 
COzH --~C<>,H. 
modification of 32. Biological activity was measured in order to establish the 
conformation preferred by retinoids on binding to various binding protein and receptor 
sites.(Table VI).14 From these studies, it was found that 57 and 58 had low activity 
compared to 32 and 56. Because the rotational profiles14 [the restriction in rotation of the 
' 
aromatic-C bonds around C(8)-C(9) (retinoic acid (3) numbering)] of molecules 56-58 
were not very different,14 it was concluded that the presence of a second methyl group on 
the double bond does not allow the compound to adopt ~e conformation which favors 
binding to the protein.14 Thus, all of these studies reinforce the importance of determining 
structure-activity relationships in the design of new retinoids. The activities of selected 
retinoids in ODC, TOC and HL-60 assays are compared in Table VII. 
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TABLE VI 
BIOLOGICAL ACTIVITY OF SELECTED STRAINED RETINOIDSa 
Retinoid 
3 
57 
58 
.OC02H 
~-.& 
59 
COzH 
aReference 14. 
TOCh 
IDso.nM 
0.01 
0.007 
>lad 
> O.ld 
0.003 
ODC 
IDso. nM 
0.04 
0.03 
142 
3.2 
2.2 
hTOC: tracheal organ culture assay (reversal of keratinization). 
CRABP 
Binding 
IDso, ~c 
1.0 
1.0 
1.0 
4.8 
1.6 
cconcentration of retinoids required to inhibit binding of 2.5 ~ all-trans-retinoic 
acid (3) by 50%. 
dffighest concentration of retinoid screened. 
TABLEVIT 
TOC, ODC AND HL-60 ASSAY OF SELECTED HETEROAROTINOIDS 
Retinoid ED so 
1 x w-11 b 
6 X 10-6 c 
C02Et 
1 x w-11 c 
s x w-11 b 
d 
% Inhibitiona 
of control 
(Dose: 1.7 nmol) 
ggb 
42b 
43b 
HL-60 
(M) 
1 x w-7 
d 
>3 X 10-6e 
d 
a% inhibition= [100 x ODC activity (retinoid)-ODC activity (control)]/ODC 
activity (control). 
bSee Reference 13. 
csee Reference 72. 
dnata not available. 
esee Reference 66. 
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CHAPTER II 
RESULTS AND DISCUSSION 
Synthesis of New Heteroarotinoids 
It has been possible to synthesize several new and novel heteroarotinoids as illustrated 
60, G = CH3, 
61, G = CH3, 
R=Et 
R=H 
OR 
G 
OR 
0 
62, G = CH20H, R = Et 
63, G = CHO, R = Et 
64, G = C02H, R = Et 
in 60-64. In addition we have been able to optimize certain key steps in our syntheses as 
shown in the following sequence. A comparison of the yields obtained, via optimized 
conditions with those previously reported, is also shown in the reaction sequence. 
OH 
C:o 
OMe 
C:o ... 
65 66 95% (vs 94%)56 
24 
66 95% (vs 94%)56 
69 Crude 98% 
(pure 67% vs 87% )56 
1. LiAlJLVether/ A/24 h 
1. H3CMgi!ether, 
A(12 h)/RT (16 h~ 
1. A1Cl3/CH3C(O)Cl 
,. CH3N02/RT124 h 
2. 6 M HCl (OOC) 
2. EtOAc/HCl/OoC/30 min. 
OH 
70 91% (vs 83%)56 
67 93% (vs 83% )56 
1. A1Cl3 /CH3NOz, 
RT/26 h, 
2. 6MHC1 
68 92% (vs 76%)56 
71 96% (vs 96% )56 
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Since ethyl3-formylbenzoate (72) was an essential reagent to combine with the Wittig 
reagent from 71, an independent synthesis for 72 had to be initiated. As a result of X-ray 
diffraction data and molecular modeling studies, performed in collaboration with Dr. van 
der Helm at the University of Oklahoma, it was discovered that the superimposition of 
26 
methyl (E)-[2-(2,3-dihydro-3,3-dimethylbenzo[b]thien-5-yl)-1-propenyl]benzoate (45)21 
upon the structure of trans-retinoic acid (3) gave an excellent "fit" except for the carbonyl 
group in the para position (see structure on page 18). Initial examination suggested that the 
"fit" would be improved if the carboxyl group were in a meta position. Moreover, with a 
six-membered oxygen containing ring, rather than a five-membered ring as in 45, the "fit" 
might be closer to optimal. Thus, one of the major objectives was to obtain ester (E)-60 
and acid (E)-61. This necessitated the development of synthesis of ethyl 3-
formylbenzoate72 (72) which was accomplished by the route shown. Separation of (E)-
60 and (Z)-60a was achieved via the use of the Chromatotron (9.7:0.3, hexane:ether) with 
silica gel. 
73 
C2HsOH/C6lf6 
HzS041' LV48 h .., 
(E )-60 (58%) 
+ 
(Z )-60a (5%) 
C02Et 
74 (97%) 
1. n-BuLi!RT/30 min 
71/ether 
2. -78.C/ 72 
3. -7s·c to RT/48 h 
C02Et 
6yOM 
OAc 
75 (81 %) 
CzHsOH/H20 
H2S04 
LVl h 
72 (47%) 
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Since metabolites of heteroarotinoids (E)-60 and (E)-61 may be oxidized in vivo, 
attention was directed towards the synthesis of 62-64. Synthetic schemes (illustrated on 
the next page) were developed to utilize certain oxidizing conditions to give control the 
extent of oxidation. Since it is believed that the carboxyl group is important for a retinoid 
to bind in vivo to cRABP,35 acid (E)-61 (91 %) was obtained by the saponification-
neutralization of ester (E)-60 via boiling the mixture (E)-60 in ethanol and sodium 
hydroxide for 6 h. In order to obtain acid (E)-61 as a solid, devoid of the other (Z)-61, it 
was imperative to use pure starting ester (E)-60. Traces of (Z)-60 were separated via use 
of chromatography on the chromatotron. 
The mixture used to oxidize (E)-60 with high regioselectivity involved six equivalents 
of SeOz12 in 95% ethanol at reflux for 24 h. After filtering off the dark elemental 
selenium, workup gave a pale yellow oil of alcohol. The oil contained a mixture of (E)-62 
(26%) and (Z)-62a (5%), both the isomers of the aldehyde 63 [12%; (E)-63:(2)-63 = 
9:1] and some starting ester [20%, (E)-60 and (Z)-60 = 8:2 )]. Separation of alcohol (E)-
62 and (Z)-62 was effected by using chromatography on 4 mrn thick plate of silica gel on 
the Chromatotron (8:2, hexane:ether was used as the eluting solvent). Evaporation of the 
solvent gave pure alcohol (E)-62 (26%). An attempt to increase the yield of the (E)-62 by 
increasing either the amount of Se02 or the reaction time (or both) resulted only in an 
increase in the ratio of the (E)-62:(2)-62 with a slight increase in the yield of aldehyde 
(E)-63. It was possible, however, to obtain aldehyde (E)-63 in moderate yields (46%), 
directly from the ester (E)-60 by decreasing the amount (by 50%) of solvent (95% ethanol) 
used originally and by increasing the amount of Se02 [by 33%, (from 0.095 M to 0.203 
M)]. Oxidation of the allylic alcohol (E)-62 to the corresponding aldehyde (E)-63 was 
achieved in good yields (77%) by using activated Mn022 in methylene chloride at RT (24 
h). Clear crystals of the aldehyde (E)-63 were obtained upon recrystallization of the crude 
product from absolute ethanol. Acid (E)-64 was prepared by oxidation of aldehyde (E)-63 
SeOz (0.095 M 
CzHsOH 
LV24h 
(E)-60 (20%); (Z)-60 (5%) 
+ 
(Z)-62 (5% ) + 
+ 
(E)-63 (12%); (Z)-63 (3%) 
C02Et 
(E)-60 
SeOz (0.203 M) 
CzHsOHiLV 26 ~ 
(lesser amount 
ofCzHsOH) 
1. CzHsOH/HzO 
NaOH/LV 6h 
2. HCI (O"C) 
(E)-61 (92%) 
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OH 
0 
(E)-62 ( 26%) 
C02Et 
0 
(E)-63 [77% 
based 
on (E)-62] 
H 
. t-BuOH/HzO 
NaCIOz/NaHzP04 
Resorcmol 
RT/ 24 h 
. HCI 
(E)-64 (97%) COzEt 
with sodium chlorite in a solution of t-BuOH/water buffered by sodium monobasic 
phosphate. Resorcinol was added as a chlorine scavenger, and the reaction mixture was 
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stirred at room temperature for 24 h.42 This unique reaction shows promise in these types 
of systems for effecting regiospecific oxidation of aldehyde groups. Acid (E)-64 was 
obtained in very high yield (97%) as a yellow solid and could be recrystallized from 
absolute ethanol. 
Purification of New Heteroarotinoids 
The heteroarotinoids synthesized were purified using chromatography mostly with the 
aid of the Chromatotron. Silica gel plates ( 4 mm thick) were prepared and the separation of 
the compounds were effected by eluting with suitable solvents. Ester (E)-60 was separated 
from ester (Z)-60 using hexane:ether (0.97:0.03) as the eluting solvent system. Alcohol 
(E)-62 was purified by passing the crude product through a 4 mm thick plate of silica gel 
on a Chromatotron using hexane and ether (8:2). The solvent system used to separate 
aldehyde (E)-63 was also hexane and ethyl acetate (8:2). Owing to the considerable 
difference in the Rr values of the ester (E)-60 (highest Rr value), alcohol (E)-62 (lowest Rr 
value), and aldehyde (E )-63 [Rf value is between the Rr values of (E)-60 and (E)-62, but 
closer to the latter], it was possible to separate the compounds using chromatography. 
Care was exercised to store the purified products quickly in the dark in a freezer. Under 
these conditions, the melting points did not change over long periods, but the compounds 
may not be stable at higher temperatures or in light as has been true for other 
heteroarotinoids. 
Synthesis of Precursors of The Heteroarotinoids 
Since the precursors 65-70 of key synthon 71 were known and since the expense of 
the overall synthesis was high, it became an important phase of the work to develop 
improved methodology to optimize the individual steps for each precursor. This is also a 
necessity for any future work in which a C-14 label is introduced into the system for 
metabolic studies. The yield of ester 66 was high and not very much improved from 
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previous work. However, conversion of the ester to alcohol 67 was increased (from 83% 
to 93%) by heating the reaction mixture at reflux for 12 hours followed by stirring at room 
temperature for 16 hours. Cyclization of alcohol67 to ether 68 was sharply enhanced by 
periodic addition of 67 to a suspension of AlCl3/nitromethane. Stirring this mixture at RT 
for 26 hours, followed by careful acidification with 6 M HCl, gave the best result. 
Acetylation of ether 68 with H3C(O)Cl! AlCl3 was promoted via a new set of conditions. 
To a stirred solution of ether 68 in nitromethane was added dropwise a mixture of AlCl3 
and acetyl chloride in nitromethane. This procedure, followed by very careful acidification 
and stirring at room temperature for 24 h, led to crude ketone 69 (98%) as a brown oil. 
Although IR analysis showed this product to be identical with that in the literature, 
because of the coloration of the oil, vacuum distillation was needed to give pure, colorless 
ketone 69. Unfortunately, this latter process resulted in some loss of product (67%). It is 
conceivable that the brown oil could be used directly without distillation. 
Reduction of ketone 69 to alcohol 70 proceeded well with LiA'IR4/ether and gave a 
good return of product (91% versus 83%56). The workup involved careful destruction of 
the excess LiA'IR4 with ethyl acetate below 5°C in order to prevent dehydration of the 
benzyllic alcohol to the corresponding alkene. Previous experience with secondary and 
tertiary alcohols in related chroman systems demonstrated a clear tendency to undergo 
elimination under less than neutral conditions as exist in the decomposition of the LiAfH4. 
Stirring a suspension of Ph3P·HBr and alcohol 70 in methanol at room temperature for 
24 h gave a clear oil which was triturated with dry ether to produce white flakes of salt 71 
in essentially the same yield as previously recorded. However, the overall yield of 71 
starting from acid 65 was 47.6% which is a slight improvement over that (42.1 %)56 stated 
earlier. Since aldehyde 72 was somewhat unstable and vulnerable to absorbing water, salt 
71 was dried at high vacuum for 12 h prior to immediate conversion to the corrresponding 
Wittig reagent in ether. Treatment of this Wittig reagent from 71 in ether with aldehyde 72 
at -78°C in the dark was initiated at once. The reaction mixture was stirred for 48 hours 
31 
with a concomitant increase in temperature from -78° to room temperature. The resulting 
oil was subjected to chromatography with the Chromatotron from which (E)-60 was 
isolated. 
Aldehyde 72 has been reported but the techniques required were not well delineated in 
the patent, and thus a scheme had to be devised. The crucial step proved to be the 
oxidation of ester 74 (from acid 73) which required the addition of small increments of 
Cr03 at OoC in the presence of HOAc/Ac20. A white pasty ester 75 formed and was 
hydrolyzed immediately to the formyl ester 76 in moderate yield (47%). Undoubtedly the 
lower yield resulted from the susceptibility of aldehyde 76 to air oxidation and to its partial 
solubility in water from which it had to be extracted. 
It is worthwhile to mention that all of the above modifications of procedures and the 
new methods developed are the end results of considerable effort after examination of many 
variables in terms of reaction conditions. Consequently, the preparations included herein 
afforded the somewhat light sensitive final products in the most consistent manner to date. 
All of the members of 60-64 appear to be stable when stored in the dark and very cold but 
may change with standing. No investigation has been made of the long term stability 
characteristics of the new heteroarotinoids recorded herein. 
All ultraviolet spectra indicate some conjugation (Plates XXVII, XXXI, XXXVIII, 
XLII and XXXXl V). A preliminary communication from Dr. van der Helm at the 
University of Oklahoma suggests that solid (E)-60 has the phenyl ring slightly turned out 
of the plane of the chroman ring and the central double bond. Molecular graphic strudies 
have not been completed as yet but again preliminary results suggest the compound may 
"fit" better with trans-retinoic acid (3) than did 45 described previously (page 18). 
However, in (E)-60, there is some distortion in the solid state. We are currently evaluating 
these early data and expect the final version shortly to be made ready for publication. This 
information will also guide our future strategy for designing modified systems of the type 
represented by (E)-60. In addition, we have submitted (E)-60 and related systems to Dr. 
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A. K. Verma of the Cancer Center (Oncology Department) at the University of Wisconsin 
in Madison, Wisconsin. Preliminary results suggests that several related systems do 
markedly retard growth of several lines of cancerous cells. Work is also in progress to 
determine if (E)-60 and related heteroarotinoids will bind to a' certain proteins as does 
trans-retinoic acid (3) for transport in the cell. 
Suggestions for Future Work 
The idea of introducing the ester funtionality in the meta position of the aryl ring is 
based on the concept that a better "fit" would enhance the ability of the heteroarotinoid to 
mimic trans-retinoic acid (3), thereby increasing the activity of the heteroarotinoid. If the 
biological assays confrrm the validity of this suggestion, compounds with slightly modified 
structure should be synthesized for the examination of the activities. Since the sulfur 
analogues of heteroarotinoids10,21,41 have proven to be somewhat more active than their 
oxygen counterparts in certain assays,41 the sulfur analogues of compounds 60-64 are 
defensible target molecules, such as structures 76-80 below. 
76, G = CH3, 
77, G = CH3, 
R=Et 
R=H 
OR 
G 
OR 
0 
78, G = CH20H, R = Et 
79, G = CHO, R = Et 
80, G = C02H, R = Et 
CHAPTER Ill 
EXPERIMENTAL 
General Information 
All reactions were performed under N2 with magnetic stirring unless otherwise specified. 
Evaporation of all solvents was effected with a rotary evaporator (Y amato; model RE-46) 
unless otherwise stated. NMR spectral data on solutions (DCCl3) were obtained using a 
Varian XL-300 spectrometer with lH and 13C data being taken at 299.99 Hz and 75.4 Hz 
with reference to TMS in d values or ppm, respectively. IR spectra were recorded on a 
Perkin-Elmer 681 spectrophotometer as films or in KBr pellets while UV data were 
obtained in 95% ethanol on a Varian DMS 200 UV-Visible spectrophotometer [equipped 
with an Epson LX-800 professional computer printer]. Melting points were determined 
with a Fischer-Johns melting 'point apparatus and were uncorrected. 
Compounds 66-71 were prepared by considerable modifications of literature56 
procedures. Elemental analyses were provided by Galbraith Laboratories, Incorporated, of 
Knoxville, Tennessee. The exact masses of certain compounds were obtained from the 
mass spectral laboratory with a VG-analytical ZAB 2.,.SE-high resolution, reversed 
geometry mass spectrometer. 
Methyl3-Phenoxypropionate (66) 
A solution of 3-phenoxypropionic acid (65, 11 g, 66.19 mmol), concentrated H2S04 
(0.3 mL) in methanol (170 mL) and benzene (200 mL) was boiled (28 h) in a single-
necked, 500-mL, round-bottomed flask fitted with a Dean-Stark apparatus and a spiral 
condensor (N2). A clear yellow solution formed and it was allowed to cool (1 h) to room 
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temperature (RT). After concentration (to 150 mL), the residual solution was diluted 
(H20, 100 mL) and extracted (ether, 4 x 40 mL). The combined organic phases were 
washed with saturated NaHC03 (3 x 40 mL), water (2 x 50 mL), and saturated brine (1 x 
50 mL). After the solution was dried (Na2S04, 8 h), the solvent was evaporated [rotovap 
followed by high vacuum (0.3 mm) at 50-60°C(water bath) for 15 min] to give 11.41 g 
(95%) of methyl 3-phenoxypropionate (66) as a colorless liquid with a strong odor. The 
compound was used without further purification since spectral data (IR, lH, 13C) matched 
those previously reported (1it56 bp 69-71 OC/0.03 mm). This method proved superior to 
all others reported56,72 since it gave a relatively pure product without fractional distillation. 
Moreover, this ester 66 gave a higher yield of alcohol 67 in the next step than previously 
recorded. 56,72 
2-Methyl-4-phenoxy-2-butanol (67) 
To a freshly prepared solution of methylmagnesium iodide [from 0.54 g, (22 mmol) of 
magnesium and 3.49 g (27.75 mmol) of methyl iodide in dry ether (10 mL)] was added a 
solution of methyl 3-phenoxypropionate (66, 1 g, 5.55 mmol) in dry ether (5 ml) and in a 
100-mL, 3-necked, round-botttomed flask equipped with a spiral condenser in tandem with 
a dry ice condensor, an addition funnel, and a magnetic stirrer.(N2). [During formation of 
H3CMgi, the reaction was started by addition of methyl iodide to magnesium followed by 
stirring the mixture for 10 min to give a black suspension of the Grignard reagent]. The 
final mixture (grey' in color) was heated to reflux (12 h) with stirring, was then allowed to 
cool toRT (16 h), and was finally quenched with water (30 mL, after cooling the reaction 
mixture with an ice-water bath), and a saturated solution of'NH4Cl (30 mL). Two phases 
separated, and the aqueous phase was extracted (ether, 3 x 25 mL). The combined organic 
phases were washed with saturated NaHC03 (3 x 35 mL) and water (3 x 35 mL). This 
organic solution was dried (N a2S04, with stirring for 10 h). Evaporation (rotovap and 
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then followed by high vacuum (0.3 mm) at RT for 15 min] gave 0.935 g (93 %) of alcohol 
67 as a colorless liquid. (1it56 bp 85-87°C/0.1 mm). IR (neat) 1740-1750 (C=O) cm-1; 
lH NMR and 13C NMR chemi~al shift values matched those previously reported.57,72 
The above procedure was superior to reported preparations.57,72 
4.4-Dimethylchroman or 3.4-Dihydro-4.4-
dimethyl-2H-1-benzop_yran,(68) 
A solution of 2-methyl-4-phenoxy-2-butanol (67, 0.93 g 5.16 mmol) in freshly 
distilled nitromethane (15 mL) was added dropwise (N2) to a stirred suspension of 
anhydrous AlCl3 (1.37 g 10.31 mmol, in 15 m1 CH3N02) in a 100-mL, 3-necked, round-
bottomed flask (over a period of 25 min) equipped with a condenser and an addition 
funnel. After stirring the deep red reaction mixture (RT, 26 h), ether (40 mL) was added 
followed by the slow addition of 6 M HCl (60 mL) over a period of 20 min to a chilled 
(OOC) reaction mixture. The organic layer was separated, and the aqueous layer was 
extracted (ether, 3 x 30 mL). The organic phases were combined and washed with water 
(3 x 30 mL) and brine (3 x 25 mL). After drying the solution (Na2S04, 6 h), the solvent 
was evaporated using a rotovap [then followed by high vacuum (0.3 mm Hg), 55-60°C, 
water bath, 20 min] to give the ether 68 (0.77 g, 91.59%) as a dark brown oil. Ether 68 
was used without further purification since the lH and 13C NMR spectra matched with 
literature data (bp 1it56 74-80°C/0.7 mm Hg). The above method was more efficient than 
any reported.56,72 
4.4-Dimethylchroman-6-yl Methyl Ketone or 1-(3.4-Dihydro-
4.4-dimethyl-2H-1-benzopyran-6-yl) ethanone (69) 
A mixture of anhydrous AlCl3 (9.08 g, 68.1 mmol ) and freshly distilled acetyl 
chloride (6.17 g, 78.6 mmol) and nitromethane (15 mL) was added dropwise to 4,4-
dimethylchroman (68, 8.5 g, 52.43 mmol, N2) in a 300-mL, 3-necked, round-bottomed 
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flask equipped with spiral condenser and addition funnel. After stirring the deep red-
colored reaction mixture at RT (24 h), 6 M HCl (50 mL) was added dropwise over a period 
of 20 min to a chilled (OOC) reaction mixture. The resulting mixture was stirred (10 min) 
and diluted with ether (50 mL). Two phases separated, and the aqueous phase was 
extracted (ether, 3 x 50 mL). The combined organic phases were washed with NaHC03, 
water (3 x 50 mL), and brine (50 mL). Sometimes emulsions formed which could be 
destroyed by washing with excess brine (100 mL). After drying the solution (Na2S04, 12 
h, stirring), the solvent was evaporated [rotovap and high vacuum (0.3 mm Hg), 50-60°C 
(water bath), 10 min] to a thick reddish-brown oil which was distilled (high vacuum, bp 
142-144°C/0.15 nun Hg) to give 7.14 g (67 %) of ketone 69 as a light yellow oil (lit56 78-
800C/0.7 mm Hg). TheIR, lH and 13c NMR spectra matched those of the the reported 
compound,56,72 but our method was superior. 
a. 4.4-Trimethylchroman-6-methanol or 3.4-Dihydro-
4.4-trimethyl-2H-1-benzopyran-6-methanol (70) 
A solution of the previous ketone (69, 6.0 g, 24.4 mmol) in anhydrous ether (25 ml) 
was added (15 min, N2) to a stirred suspension ofLiA:Il4 (1.67 g, 44.0 mmol) in dry ether 
(20 mL) in a 100-mL, 3-necked, round-bottomed flask with the usual setup. The mixture, a 
grey suspension, was heated to reflux for 24 h. After cooling toRT (1 h), ethyl acetate (15 
mL) was added slowly and carefully to destroy excess LiAlil4 (an ice bath was used 
to maintain the temperature of the mixture below 5oC during the addition of ethyl acetate). 
A solution ofHCl (5%, 80 mL) was then added slowly, and the resulting grey suspension 
was stirred (15 min). Ether (50 mL) was added and the resulting aqueous layer was 
separated. The aqueous layer was extracted with ether (4 x 40 mL), and the combined 
organics were washed with saturated N aHC03 (3 x 40 mL), water (2 x 50 mL), and 
saturated brine (2 x 50 mL). After the solution was dried (Na2S04, 8 h), the solvent was 
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evaporated [rotovap, followed by high vacuum (0.3 mm Hg) 50-55°C (water bath), 
15min]. The thick yellow oil solidified in a few minutes (5.66 g, 93.9%), mp 71-72°C 
(lit1·2 70-72°C); IR (KBr) 3140-3640 (OH) cm-1. All lH and 13C signals matched the 
literature values for 70. This procedure proved superior to that reported.56,72 
1-( 4,4-Dimethylchroman-6-yl)ethylltriphenylphosphonium Bromide 
or [l-(3.4 Dihydro-4.4-dimethyl-2H-1-benzopyran-6-yl)ethyll-
triphenylphosphonium Bromide (71) 
A solution of alcohol 70 (5.60 g 13.8 mmol) and triphenylphosphonium 
hydrobromide (5.63 g 16.56 mmol) was stirred at RT (N2, 24 h), in a 250-mL, three-
necked, round-bottomed flask. The pale yellow solvent was then evaporated (rotovap), 
and the resulting clear oil was triturated repeatedly with dry ether (100 mL) until 
solidification occured. The resulting white solid was suspended with stirring in dry ether at 
RT (Nz, 4 h). After filtration, a white solid 71 was obtained which was dried (110°C/2 
mm Hg) and weighed (13.3 g, 94%); mp 150-152°C.(dec) [1it56 149-155°C]. All NMR 
data (lH and 13C) matched those of the literature. 56 The compound was used without any 
further purification. The procedure herein was superior to one reported.56,72 
Ethyl3-Toluate (74) 
In a 200-mL, single-necked, round-bottomed flask, equipped with a Dean-Stark 
apparatus, a spiral condenser, and a magnetic stirrer was placed m-toluic acid (73, 10 g, 
73.4 mmol) in absolute ethanol (15 ml) and benzene (75 mL) with H2S04 (1.5 mL). The 
solution was heated at reflux (48 h), and then it was allowed to cool toRT (1 h). Water 
(75 mL) was added, and the aqueous phase was separated and extracted (ether, 3 x 40 mL) 
and then washed with saturated NaHC03 (3 x 40 ml), water (2 x 50 mL), and brine (2 x 50 
mL). The solvent was evaporated [rotovap and then high vacuum (0.25 mm Hg) at 65°C 
(water-bath) for 25 min]. A yellow oil obtained was distilled (vacuum, 0.25 mm Hg) to 
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give 17.7 g. (91%) of ester 7 4 as a colorless liquid (strong and sweet odor), bp 72-
74.C/0.250 nun [lit72 234.C/760 nun Hg)]. 
Ethyl3-Formylbenzoate (72) 
In a 200-mL, single-necked, round-bottomed flask (Nz) fitted with a condenser was 
placed ethyl 3-methylbenzoate (21, 5.0 g, 7.3 mmol), glacial acetic acid (50 mL), and 50 
mL of freshly distilled acetic anhydride with H2S04 (2.0 mL). After stirring for 15 min at 
RT, the reaction mixture was cooled to o·c (ice-salt bath). The temperature was 
maintained below 5•c (1 h) as Cr03 (8.4 g, 84.2 mmol) was added in small portions (30 
min). After stirring (2 h), the dark green reaction mixture was treated carefully with ice 
· water (150 mL) and ether (40 mL). The organic phase separated, and the aqueous phase 
was extracted [HCCl3 (3 x 50 mL) and then ether (2 x 50 mL)]. The combined organic 
phases were washed with 5% NaHC03 (3 x 40 mL), water (3 x 30 mL), and brine (2 x 25 
mL). After drying (Na2S04, 3 h), the solvent was evaporated (rotovap, followed by high 
vacuum 0.25 nun Hg, 45.C) to give the diacetate (75, 7.5 g, 81 %) as a white solid. To 
ester 75 in a 100-mL, single-necked, round-bottomed flask was added dropwise (RT, stir, 
10 min), water (8 mL), and concentrated HzS04 (1 mL). After cooling toRT, water (20 
mL) was added, the organic phase separated, and the aqueous phase was extracted with 
ether (3 x 20 ml) and HCCl3 (25 mL). The combined organic phases were washed with 
5% NaHC03 (2 x 25 mL), water (35 mL), and brine (35 ml). After drying the solution 
(NazS04, 4 h), the solvent was evaporated (rotovap, followed by high vacuum 0.2 mm 
Hg) and gave 2.59 g (47%) of 72 [1it72 278-280.C/760 mm Hg)] as a golden yellow 
liquid. The ester was used without further purification. IR (DCCl3) 2720-2740 (C(O)H), 
1700-1740 (C=O) cm-1; lH NMR (DCCL3) a 1.43 [t, 3 H, CH3], 4.41 [q, 2 H,CHz], 
7.64-8.5 [4 H, Ar-H], 10.1 [C(O)H]; 13C NMR (DCC13) ppm 14.3 [CH3], 61.4 [CHz], 
129-169 [ArC], 191.3 [C=O]. 
Ethyl (El-3-[2.3-Dihydro-4.4-dimethyl-2H-1-benzopyran-
6-yl)-1-propynyllbenzoate [(E)-60] 
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A solution of n-butyllithium in hexane (0.90 M, 3.4 mL, 3.14 mmol) was added 
dropwise (5 min, N2) to a stirred suspension of the white phosphonium salt 71 (1.29 g, 
2.42 mmol) in ether (30 mL dried over sodium ribbon) in a 100-mL, three-necked, round-
bottomed flask fitted with an addition funnel and spiral condenser. The resulting reddish-
brown mixture was cooled to -78°C (dry ice, acetone, 10 min), and a solution of ethyl 3-
fonnylbenzoate (72, 1.0 g, 5.61 mmol) in ether (25 mL) was added dropwise (10 min). 
This solution was stirred (30 min) at -78°C and then it was allowed to warm slowly toRT 
(1 h). The color of the reaction mixture was pale yellow. After stirring (48 h), the yellow 
reaction mixture was filtered, and the residual solid was washed with ether (100 mL). The 
filtrate was dried (Na2S04) and the solvent was evaporated [rotovap, followed by high 
vacuum (0.25 mm Hg), 10 min]. The solid was purified by chromatography on a 4 mm 
thick plate of silica gel (silica gel pF 254 containing gypsum) with the aid of the 
Chromatotron (Model 7924, Harrison Research). The solvent system used to separate the 
starting materials and the (E)-60 and (Z)-60 isomers was composed of hexane:ether 
[0.97:0.3]. The last fraction obtained was concentrated to give 1.4 g (60 %) of a mixture 
of esters [10:1, (E)-60:(2)-60] which was then treated with boiling ethanol (95%, 3 mL, 5 
min). The resulting solution was chilled (dry ice bath) for 24 h. A white solid precipitated 
and was treated with cold ethanol (95%, 0.5 mL) to give 0.30 g (16.2%) of needle-like 
crystals of ester (E)-60; mp 42.5-44°C. IR (KBr) 1715-1725 (C=O), cm-1. 1H NMR 
(DCCl3) a 1.39 [s, 6 H, H(9), H(lO)], 1.40 [t, 3 H, H(22)], 1.86 [t, 3 H, H(3)], 4.21 [t, 
2 H, H(2)], 4.40 [q, 2 H, H(21)], 6.76[s, 1 H, H(13)], 6.80 [s, 1 H, J = 9 Hz, H(8)], 
7.25 [dd, J = 9Hz, J = 3Hz, H(7)], 7.42 [m, J = 9 Hz, J = 3 Hz, H(5), H(16)], 7.53 
[dd, J =9Hz, J =3Hz, H(17)], 8.03 [dd, J =9Hz, J =3Hz, 1 H, H(19)] ; 13C NMR 
(DCCl3) ppm 14.35 [C(22)], 17.55 [C(l2)], 30.7 [C(4)], 31.11 [C(9), C(10)], 37.7 
[C(3)], 60.99 [C(21)], 63.13[C(2)], 116-153 [C(Ar and vinylic)] 166.72 [C(20)]. Mass 
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spectral data for C23H2603: rnle (M+) 350.1882; Found: 350.1882. Anal.for C23H2603: 
C, 78.72; H, 7.47. Found: C, 79.72; H, 7.54. 
(E )-3[2-(3.4-Dihydro-4.4-dimethyl-2H-1benzopyran-
6-yl-1-propenyl]benzoic acid [(E)-61] 
In a 2-necked, 25-mL, round-bottomed flask (N2) fitted with a spiral condenser was 
placed ester (E)-60 (mp 42-44 OC, 0.060 g, 0.17 mmol), ethanol (95%, 1.5 mL), water (3 
mL), and NaOH (0.24 g, 0.06 mmol). The resulting solution was boiled (6 h), cooled 
slowly to RT (30 min),and then chilled (OoC ) with an ice bath. Dropwise addition of 
concentrated HCl (8 drops, pH 2), resulted in the formation of a white solid. This 
precipitate was then filtered (water aspirator) using a Hersh-funnel with a suitable filter 
paper (Whatman #1). The solid was then washed with copious amounts of water (150 
mL), was air dried (12 h), and was· subjected to a high vacuum (Abderhalden with P205, 
60-62°C) to give acid (E)-61 (0.051 g, 92%) as a dry white powder; mp 182-184°C. IR 
(KBr) 2400-3450 (0-H, CH), 1690-1710 (C=O) cm-1; lH NMR (DCCl3) a 1.39 [s, 6 H, 
H(9), H(lO)], 1.86 [t, 2 H, H(3)], 2.27 [s, 3 H, H(l2)], 4.21[t, 2 H, H(2)], 6.77 [s, 1 H, 
H(13)], 7.25-7.81 [Ar-H]; I3C NMR (DCC13) ppm 17.54 [C(12)], 30.70 [C(4)], 31.9 
[C(9), C(lO)], 37.6 [C(3)], 63.1 [C(2)], 116.71-153.26 [C(Ar and vinyl)], 172.42 
[C(20), C=O].Mass spectral data for C21H2203: rnle (M+) 322.1569; Found: 322.1569. 
Anal for C21H2203: C, 78.01; H, 6.91. Found: C, 78.23, H, 6.88. 
Ethyl (E )-3-[2-(3.4-Dihydro-4.4-dimethyl-2H-1-benzopyran-
6-yn-3-hydroxy-1-propenyllbenzoate [(E)-62] 
In a 50-mL, 2-necked, round bottomed flask, equipped with a magnetic stirrer, a spiral 
condenser and addition funnel, were mixed ester (E)-60 (0.500 g, 1.42 mmol) and 
selenium dioxide (0.950 g, 8.57 mmol) in ethanol (95%, 15 mL, N2). The reaction was 
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stirred at reflux (24 h), and then the solution was cooled toRT (30, mint green in color). 
This green mixture was first filtered through a cotton plug and then through a filter paper 
(Whatman #1) to remove elemental selenium formed during the reaction. The solution was 
concentrated using rotovap to a volume of 10 mL, and ether, (25 mL) was then added. This 
mixture was washed with saturated NaHC03 (3 x 15 mL), water (2 x 25 mL), and brine (2 
x 20 mL). After drying (NazS04, 1 h), the solvent (ether:ethanol, 25:10 mL) was 
evaporated [rotovap, followed by high. vacuum 0.25 mm Hg (50-55°C)] to give a yellow 
oil which was a mixture of the alcohol [(E )-62 and (Z )-62] and the starting material (E)-
60. The mixture of alcohols was separated by chromatography on a 4-mm thick plate of 
silica gel (silica gel PF 254 containing gypsum) with the aid of a Chomatotron. The elution 
system was a mixture of hexane and ether (8:2). The last fraction from the plate contained 
alcohol (E)-62 which was devoid of any aldehyde (E)-63 or (Z)-63. [Isolation of 
aldehyde (E)-63 was a bonus since it was an original target compound]. Boiling the 
original reaction mixture with excess of selenium dioxide (greater than 10 fold excess) did 
not increase the overall yield of the alcohol (E)-62 but instead resulted in an increase of the 
ratio of both alcohols[roughly 7:3 (E)-62-:(Z)-62] and the aldehydes [roughly 7:3 (E)-
63:(2)-63]. Alcohol (E)-62 is a pale yellow viscous oil. Solidification attempts with 
different solvents such as, boiling with ethanol (both 95% and absolute, 1 mL), hexane (1 
mL), or heptane (1 mL) failed. IR (neat) 3500-3640 (0-H), 1740 (C=O) cm-1; lH NMR 
(DCCl3) a 1.2 [s, 6 H, H(9), H(lO)], 1.33 [t, 3 H, H(21)], 1.77 [m, 2 H, H(3)], 2.24 [s, 
1 H, 0 H], 4.17 [m, 2 H, H(2)], 4.30 [q, 2 H, H(22)], 4.46 [s, 2 H, H(12)], 6.67-7.75 
[Ar-H and C=CHJ; 13C NMR (DCCl3) ppm 14.2 [C(22)], 30.4 [C(4)], 30.7 [C(9), 
C(10)], 37.4 [C(3)], 60.8 [C(21)], 63.1, [C(2)], 67.8 [C(12)], 117.3-153.25 [CAr and 
C=C], 166.6[C(20), C=O]. Mass spectral data for Cz3H2604: m/e (M+) 366.1834 
observed 366.1872. Anal for C23H2604: C 75.37; H, 7.15. Found: C, 75.00; H, 7.48. 
Ethyl CE)-3-[2-(3.4-Dihydro-4.4-dimethyl-2H-l-benzopyran-6-yD-
l-propenallbenzoate [ (E)-63] 
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In a 250-mL, 2-necked, round-bottomed flask equipped with a spiral condensor, 
addition funnel, and magnetic stirrer were mixed alcohol (E)-62 (0.1 05 g, 0.287 mmol) 
and activated Mno22 (4 0.52 g, 15.7 mmol) in CHzClz (10 mL, Nz). After stirring at RT 
(24 h), the dark reaction mixture was filtered through a Buchner funnel with filter aid 
(Celite, Fisher brand, 2 g ,10 mL of CHzClz). The solid was washed with CHzClz (10 
mL), and the filtrate (and the washings) was evaporated (rotovap, followed by high 
vacuum 0.25 mm Hg) to give a yellow colored oil which was a mixture of isomeric 
aldehydes (E)-63 :(Z)-63 [8:2] and the starting material [alcohol (E)-62]. Separation was 
effected with chromatography on a 4 mm thick plate of silica gel (silica gel containing 
gypsum) with the aid of a Chromatotron. The solvent system used to elute the compounds 
was hexane:ethyl acetate (8:2). The fraction with (E)-63 was collected from the plate, 
immediately after the (Z)-63 fraction was eluted. The solvent was evaporated [rotovap, 
followed by high vacuum (0.25 mm Hg), 45-50°C] to give a light yellow oil which was 
aldehyde (E)-63 (0.8 g, 76.7% ). Boiling ethanol (absolute, 0.5 mL) was added to this oil, 
and the resulting solution was placed in a freezer (48 h). Needle-like crystals (off white in 
color) of aldehyde (E)-63 formed. These crystals were vacuum dried (Abderhalden, 60-
61 °C, 0.3 mm Hg, 24 h); mp 87.5-89°C. IR (KBr) 2710 (C(O)H), 1720 (C=O), 1690 
C(O)H cm-1. lH NMR (DCCl3) a 1.17 [s, 6 H, H(9),H(l0)], 1.34 [t, 3 H, H(22)], 1.80 
[m, 2 H, H(3)], 4.19 [m, 2 H, H(2)], 4.20 [q, 2 H, H(21)], 6.82-7.95 [Ar-H], 9.7 [s,1 
H, H(l2)]; 13C NMR (DCC13) ppm 14.2 [C(22)], 30.4 [C(4)], 30.7 [C(9), C(lO)], 37.4 
[C(3)], 60.8 [C(21)], 63.0 [C(2)], 117-155 [Ar-C], 165.8[C(20), C=O], 194.0 [C(12), 
C=O]. Anal for C23R404: C 75.80; H, 6.63. Found: C 75.85; H, 6.67. 
Ethyl <E)-3-[2-(3.4-Dihydro-4.4-dimethyl-2H-1-benzop,yran-
6-yl)-l-propanoic acidlbenzoate [(E)-64] 
43 
In a 100-mL, 2-necked, round-bottomed flask equipped with a condenser and 
magnetic stirrer was dissolved aldehyde (E)-63 (0.500 g, 1.3 mmol, N2) in t-butanol (40 
mL). After adding resorcinol (0.16 g, 1.51 mmol) to the stirred solution (RT, 10 min), an 
aqueous solution (45 mL water) containing NaCl02 (1.1 g, 12.35 mmol) and Nal-I2P04 
(1.32 g, 9.61 mmol) was added dropwise (RT, 15 min). After stirring (RT) for 24 h, the 
reaction mixture was acidified (pH 5, 6M HCl, 1 mL), and then the solvent (t-butanol) 
was evaporated using a rotovap. The solution was extracted with benzene (4 x 35 mL), 
and the combined organic phases were washed with water (2 x 50 mL) and brine (50 mL). 
After drying (Na2S04, 4 h), the solvent was evaporated using a rotovap [followed by high 
vacuum (0.3 mm Hg), RT, 24 h] to give acid (E)-64 (0.49 g,1.29 mmol 98%) as a thick 
yellow solid. Yellow crystals of acid (E)-64 were obtained upon recrystallization with 
boiling absolute ethanol (2 mL); mp 154-155°C. IR (KBR) 2450-3450 (0-H, CH) 1685-
1710 (C=O) cm-1; lH NMR (DCCl3) a 1.17 [s, 6 H, H(9),H(10)], 1.35 [t, 3 H, H(22)], 
1.80 [m, 2 H, H(3)], 4.20 [m, 2 H, H(2)], 4.31 [q, 2 H, H(21)], 6.83-7.95 [Ar-H], 10.7 
[s,1 H, H(12)]. 13C NMR (DCCl3) ppm 14.2 [C(22)], 30.5 [C(4)], 30.8 [C(9), C(lO)], 
37.5 [C(3)], 61.1[C(21)], 63.3 [C(2)], 117.4-153 [Ar-C], 166.8 [C(20), C=O], 173.3 
[C(12), C=O]. Anal for C23H240s: C 72.61; H, 6.36. Found: C 72.35; H, 6.42. 
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